Literature DB >> 9464197

Controlled comparison of electrophysiological sleep in families of probands with unipolar depression.

D E Giles1, D J Kupfer, A J Rush, H P Roffwarg.   

Abstract

OBJECTIVE: This study presents polysomnographic data and psychiatric history for parents and siblings of probands with unipolar depression and short REM latency, probands with unipolar depression and normal REM latency, and normal comparison probands.
METHOD: Parents and adult siblings (N = 252) of probands (N = 64) were evaluated for lifetime history of psychiatric disorders and were studied in the sleep laboratory for 3 nights.
RESULTS: REM latency predicted lifetime history of major depression. Short REM latency was also associated with slow wave sleep deficits. Rate of short REM latency in relatives of depressed probands with short REM latency quadrupled the rate in relatives of both depressed probands with normal REM latency and normal probands. Lifetime risk of depression was almost twice as high in relatives of depressed probands with short REM latency as in relatives of depressed probands with normal REM latency.
CONCLUSIONS: Short REM latency and slow wave sleep deficits are familial. Short REM latency is associated with increased risk of major depression beyond the familial risk associated with a depressed proband. Polysomnographic abnormalities also occurred in unaffected relatives. Although the data can be considered only suggestive, these findings indicate that polysomnographic abnormalities may precede the clinical expression of depression and may be useful in identifying those at highest risk for the illness.

Entities:  

Mesh:

Year:  1998        PMID: 9464197     DOI: 10.1176/ajp.155.2.192

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

1.  Sleep disorders in psychiatric practice.

Authors:  Waldemar Szelenberger; Constantin Soldatos
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

2.  Sleep Disturbances in Pediatric Depression.

Authors:  Uma Rao
Journal:  Asian J Psychiatr       Date:  2011-12

3.  The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects.

Authors:  Elisabeth Friess; Sieglinde Modell; Hans Brunner; Hirokuni Tagaya; Christoph J Lauer; Florian Holsboer; Marcus Ising
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-05-26       Impact factor: 5.270

4.  Polysomnographic sleep characteristics of generally-anxious and healthy children assessed in the home environment.

Authors:  Michelle A Patriquin; Thomas A Mellman; Daniel G Glaze; Candice A Alfano
Journal:  J Affect Disord       Date:  2014-03-12       Impact factor: 4.839

5.  Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study.

Authors:  Lynn A Schroeder; Olivier Rufra; Nicolas Sauvageot; François Fays; Vannina Pieri; Nico J Diederich
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

6.  Polysomnographic sleep patterns of non-depressed, non-medicated children with generalized anxiety disorder.

Authors:  Candice A Alfano; Katharine Reynolds; Nikia Scott; Ronald E Dahl; Thomas A Mellman
Journal:  J Affect Disord       Date:  2012-09-29       Impact factor: 4.839

7.  Reduced sleep quality in healthy girls at risk for depression.

Authors:  Michael C Chen; Hannah W Burley; Ian H Gotlib
Journal:  J Sleep Res       Date:  2011-06-27       Impact factor: 3.981

8.  Ethnic differences in electroencephalographic sleep patterns in adolescents.

Authors:  Uma Rao; Constance L Hammen; Russell E Poland
Journal:  Asian J Psychiatr       Date:  2009-03-01

9.  The natural history of insomnia: acute insomnia and first-onset depression.

Authors:  Jason G Ellis; Michael L Perlis; Célyne H Bastien; Maria Gardani; Colin A Espie
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

10.  Risk markers for depression in adolescents: sleep and HPA measures.

Authors:  Uma Rao; Constance L Hammen; Russell E Poland
Journal:  Neuropsychopharmacology       Date:  2009-03-04       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.